Heart Failure Clinical Trial

Novel Cardiac Rehabilitation in Patients Heart Failure and Preserved Ejection Fraction

Summary

Patients with HFpEF suffer from exercise intolerance, increased risk for hospitalization and mortality, and poor QOL. Unlike patients with HFrEF, no drug or device therapies appear to be consistently beneficial in treating these problems. However, increasing evidence suggests that exercise training is effective for both partially reversing exercise intolerance and improving quality of life in these patients. Most such trials to date have been conducted in controlled research setting, versus integrating these patients in to a standard CR program. Also, since functional capacity is related to outcomes in these patients, exercise strategies aimed at further improving fitness are warranted. One such strategy is using higher intensity interval training (HIIT) in the CR setting, a strategy shown to be effective in patients with other types of CVD. This project is designed to test the feasibility of incorporating these patients into the CR setting, and training them using a methodology (i.e., HIIT) already shown to yield (in other patients with CVD) greater gains in fitness when compared to what was achieved using standard MCT alone.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

NYHA class II or III symptoms
Referred by physician to CR with echocardiographic evidence of HFpEF defined as an ejection fraction ≥ 50 % and moderate to severe (grade II-III) diastolic dysfunction.
≥ 50 years of age
Free of orthopedic or other medical problems that would limit participation in CR
Peak VO2 on baseline cardiopulmonary exercise test (CPX) < 24 mL/kg/min in men and <21 mL/kg/min in women

Exclusion Criteria:

Systolic dysfunction, per ejection fraction < 50%; those with mild (grade I) diastolic dysfunction
Initial clinical responses observed during first 3 visits in CR or baseline exercise test that would preclude participation in study over-all (e.g., new onset/troublesome arrhythmia that warrants further investigation) or undergoing HIIT (e.g., claudication, balance issue)
Patients with exercise induced angina during CR or CPX testing or ST segment depression representative of myocardial ischemia during CPX testing
Pregnant or planning to become pregnant
Any patient recently hospitalized for heart failure will have to wait at least 2 weeks before starting CR, or until clinically stable per physician(whichever time period is greater)
Atrial fibrillation

Study is for people with:

Heart Failure

Estimated Enrollment:

16

Study ID:

NCT02762825

Recruitment Status:

Terminated

Sponsor:

Henry Ford Health System

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Henry Ford Hospital
Detroit Michigan, 48202, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

16

Study ID:

NCT02762825

Recruitment Status:

Terminated

Sponsor:


Henry Ford Health System

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider